Qiao Peng
Naval University of Engineering(CN)Tongji Hospital(CN)Huazhong University of Science and Technology(CN)Nanjing Medical University(CN)
Publications by Year
Research Areas
Oral Health Pathology and Treatment, Immune cells in cancer, Cancer Immunotherapy and Biomarkers, Pelvic floor disorders treatments, Pancreatic and Hepatic Oncology Research
Most-Cited Works
- → MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway(2013)277 cited
- → IL-6/STAT3 pathway induced deficiency of RFX1 contributes to Th17-dependent autoimmune diseases via epigenetic regulation(2018)123 cited
- → Preclinical development of a novel CD47 nanobody with less toxicity and enhanced anti-cancer therapeutic potential(2020)111 cited
- → Methionine restriction promotes cGAS activation and chromatin untethering through demethylation to enhance antitumor immunity(2023)104 cited
- → A potent neutralizing nanobody against SARS‐CoV‐2 with inhaled delivery potential(2021)101 cited
- → miR-615-5p is epigenetically inactivated and functions as a tumor suppressor in pancreatic ductal adenocarcinoma(2014)99 cited